NBRV - Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2021 Results - Earnings Call Transcript

Nabriva Therapeutics plc (NBRV) Q2 2021 Results Conference Call August 5, 2021 4:30 PM ET Company Participants Dan Dolan - Chief Financial Officer Ted Schroeder - Chief Executive Officer Conference Call Participants Suji Jeong - Jefferies Presentation Operator Good day, and thank you for standing by. Welcome to the Nabriva Therapeutics Second Quarter 2021 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Mr. Dan Dolan, Chief Financial Officer. Please go ahead. Dan Dolan Thank you, and good afternoon, everyone. Welcome to Nabriva's conference call and webcast where we will discuss the second quarter 2021 earnings and also provide a business update. Slides for today's presentation are posted on the company's website, www.nabriva.com, and can be found under the Investors tab

For further details see:

Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2021 Results - Earnings Call Transcript